The Real Question for the $63 Billion AbbVie-Allergan AcquisitionJune 25, 2019by Joseph HargettGreat StuffI know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]
This Biotech Billionaire Loves This Risky StockApril 11, 2018by Brian ChristopherTechnology, TrendingThere is a chance you will lose money if you buy today’s stock. But if you’re willing to take on a little risk, I have an opportunity for you that could be very profitable.
Newsletter Sign Up
Subscribe to our Banyan Edge newsletter to get financial insights and tips from our top investment experts. Start investing with an edge today!
Get the best of Banyan Hill, straight to your inbox today for FREE!
Editor of Strategic Fortunes and three elite services
WHAT READERS ARE SAYING..
“Looks like I have finally found the right person to learn and grow from.”
- James
“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”
- Chris K.
“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”
- Warren O
Company not found
Please use the Find By Symbol to continue your search or Select from suggestions below